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Abstract: The emergence and rapid spread of multidrug-resistant bacteria strains are a public health 
concern. This emergence is caused by the overuse and misuse of antibiotics leading to the evolution 
of antibiotic-resistant strains. Nanoparticles (NPs) are objects with all three external dimensions in 
the nanoscale that varies from 1 to 100 nm. Research on NPs with enhanced antimicrobial activity 
as alternatives to antibiotics has grown due to the increased incidence of nosocomial and 
community acquired infections caused by pathogens. Machine learning (ML) tools have been used 
in the field of nanoinformatics with promising results. As a consequence of evident achievements 
on a wide range of predictive tasks, ML techniques are attracting significant interest across a variety 
of stakeholders. In this article, we present an ML tool that successfully predicts the antibacterial 
capacity of NPs while the model’s validation demonstrates encouraging results (R2 = 0.78). The data 
were compiled after a literature review of 60 articles and consist of key physico-chemical (p-chem) 
properties and experimental conditions (exposure variables and bacterial clustering) from in vitro 
studies. Following data homogenization and pre-processing, we trained various regression 
algorithms and we validated them using diverse performance metrics. Finally, an important 
attribute evaluation, which ranks the attributes that are most important in predicting the outcome, 
was performed. The attribute importance revealed that NP core size, the exposure dose, and the 
species of bacterium are key variables in predicting the antibacterial effect of NPs. This tool assists 
various stakeholders and scientists in predicting the antibacterial effects of NPs based on their p-
chem properties and diverse exposure settings. This concept also aids the safe-by-design paradigm 
by incorporating functionality tools. 
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1. Introduction 
Antibiotic resistance is increasing to alarmingly high levels, the resistance 
mechanisms threatening our ability to treat common infectious diseases which leads to a 
global health risk [1]. Antibacterial agents are compounds that can be classified as either 
bactericidal, completely inhibiting and eradicating bacteria, or bacteriostatic, which 
inhibits bacterial growth [2]. However, several factors may influence this classification, 
including growth conditions, bacterial density or test duration [3]. More importantly, the 
effectiveness of most compounds depends on the type of bacteria (Gram-positive and 
Gram-negative bacteria) exposed to [2,4]. The majority of existing antibacterial agents are 
chemically modified natural compounds, e.g., β-lactamines (i.e., penicillin), 
cephalosporins or carbapenems; or purely natural products (i.e., aminoglycosides), and 
purely synthetic antibiotics, such as sulfonamides [2,5]. As a result of the recurrence of 
infections, the microorganisms develop resistance due to inherent genetic changes [6,7]. 
With the excessive use or misuse of antibacterial agents, the emergence of resistance to 
antibacterial drugs has become one of the most significant public health challenges [8,9]. 
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While bacteria are normally found in nature in the form of individual cells, they may 
also develop multicellular structures called biofilms; densely packed groups of bacteria 
that contain one or more species of bacteria [10]. The biofilm provides mechanical stability 
and adhesion to a wide variety of surfaces both biotic and abiotic, including human 
tissues, surgical devices, implants, and industrial equipment [11,12]. Biofilms are a major 
issue in almost all industries, contaminating equipment and the surrounding 
environment, resulting in reduced quality of products and economic losses [13,14]. 
Bacterial biofilms contribute to microbial resistance and therefore play a significant role 
in therapeutic failure, resulting in chronic bacterial infections [15,16]. Considering the role 
of biofilm in antibiotic resistance, the elimination of bacteria needs multiple drugs with 
potential side effects in humans and environments, as a result of the need for high doses 
of common disinfectants and antibiotics there is the increase in toxicity, cost and duration 
of therapy; therefore, new treatments are necessary to eliminate bacteria. 
Nanoparticles (NPs) are widely used due to their unique and size-dependent 
physical and chemical (p-chem) properties. They exhibit enhanced antimicrobial 
capacities [17], making them a suitable alternative to antibiotics. NPs have been studied 
for their capacity to inhibit microbial infections [18] and prevent bacterial colonization on 
various surface devices such as catheters [19] and prostheses [20] by eradicating biofilms 
[21,22]. Research into NPs is of great interest as they can be applied in various fields such 
as medicine, food industry, and manufacturing, while retaining their original unique 
functions [23–26]. Over the past few decades, the search for new antimicrobial substances 
has been central to many research areas, both in public and private research centers, for 
the reduction of nosocomial and foodborne infections [27–29]. 
Metal and metal oxide NPs (MO-NPs) are promising agents against a broad spectrum 
of microorganisms including drug-resistant strains [17,30,31]. The exact mechanisms of 
NP toxicity against different bacteria depends on surface modification, intrinsic 
properties, composition, and the bacterial species. The main mechanisms of the 
antibacterial effects of NPs are: (1) mechanical damage to the cell wall through 
electrostatic interaction; (2) oxidative stress by means of the generation of reactive oxygen 
species (ROS); and (3) disruption of cell and protein structures as a result of metal cation 
release [32]. Among MO-NPs, the most promising and widely studied ones are Fe3O4 and 
ZnO [33]. Fe3O4 NPs release Fe2+ ions, which cause the generation of ROS after a reaction 
with hydrogen peroxide (H2O2) and induces oxidative stress in the cell, as a result of which 
the bacteria cell dies [34,35]. ZnO NPs produce H2O2 and hydroxyl radicals (OH−), but not 
superoxide (O 
 ) and have weak mutagenic capability that induces frameshift mutation in 
bacterium [36–38]. Metal NPs such as AgNPs have an oligodynamic effect (the biocidal 
effects of metals) due to their large surface areas and have the ability to accumulate at the 
cell wall and bind with bacterial biomolecules [39] and penetrate the cells [40], generating 
ROS and free radicals, and act as modulators in the signal transduction pathways of 
microorganisms [41–43]. 
Antibacterial activities of NPs depend on two main factors: (i) p-chem properties, 
such as composition, surface modification and intrinsic properties, and (ii) the type of 
bacteria species [2,44–46]. For a better understanding of their properties and effects, a 
computational tool can assist in reducing the design space by predicting the characteristics 
of desired NPs before synthesis, which helps to decrease the experimental trial and error 
work. For example, tools have been employed to predict the three-dimensional structure 
of metallic nanoparticles [47,48] in order to determine the functional composition of the 
protein corona of NPs [49]. 
Artificial intelligence (AI) is a branch of computer science that has attracted much 
interest in many fields due to its problem-solving, decision-making and trend recognition 
capabilities. Machine learning (ML), a subset of AI, focuses on the ability of algorithms to 
learn from data while organizing the information they process. ML is a method of data 
analysis that automates model building while not requiring deterministic insights, 
bypassing in-depth comprehension and bridging input data directly to the outcome [50]. 
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Moreover, these tools are fast and inexpensive, and they rely on information inputs rather 
than physical test materials. In addition, they can predict the impact of materials not yet 
synthesized, thereby contributing to safe-by-design approaches [51]. ML has been 
effectively employed for the prediction of toxicity profiles of NPs [52–56] and for the 
development of new antibiotics [57,58]. Furthermore, models for the prediction of the 
antimicrobial resistance for specific bacteria have been demonstrated [59–61]. For 
example, Khaledi, Weimann et al. [60] investigated the antimicrobial susceptibility of 
Pseudomonas aeruginosa predicted by genomic and transcriptomic markers. Yang, Niehaus 
et al. [62] employed algorithms for the identification of Mycobacterium tuberculosis 
resistance against several tuberculosis drugs. Her and Wu [59] demonstrated the 
prediction of antimicrobial susceptibility of Escherichia coli by using the pangenome-based 
ML approach. 
To the best of our knowledge, there is no study that uses ML to predict the 
antibacterial effects of NPs. We propose an ML tool predicting the antibacterial activity of 
NPs against a vast range of Gram-positive and Gram-negative bacteria. This tool predicts 
the antibacterial effect by exploring p-chem properties, experimental exposure conditions 
and bacteria characteristics as inputs. We gathered in vitro experimental data from 
literature studies and structured them into a comprehensive dataset (Supplementary 
Materials (S1)). The present approach allows the screening of NPs, predicting their 
capacity to eradicate bacteria, saving time and reducing costs by reducing the amount of 
trial and error in the lab. Such an approach would help scientists to prevent bacterial 
growth that can be harmful to human health, environments and industrial components 
that are subjected to biofilm formation and bacterial growth [63]. 
2. Materials and Methods 
Approach 
Figure 1 demonstrates the roadmap followed for the model implementation. Initially, 
studies related to the antibacterial effect of NPs are collected and data extraction is 
performed relating to p-chem properties of NPs, exposure conditions and information 
about the exposed bacteria. The original dataset was evaluated for completeness. Data 
pre-processing followed, including standardization [64], one hot encoding and one data 
split [65]. To find a model with good predictivity, we trained and validated several 
regression models. Finally, an analysis of attribute importance [66,67] was conducted to 
reveal the attributes that most influence the prediction of the results. 
 
Figure 1. Model development workflow. 
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2.1. Data Collection 
A literature search was carried out in January 2021 for studies that investigated the 
impact of NPs on the elimination or inhibition of bacteria and consequently the 
degradation of biofilm. The articles collected were published between 2010 and 2020 
including different keywords, such as “antibacterial”, “antimicrobial”, “bactericidal”, 
“biofilm” and “anti-fungal” effects. We determined to evaluate silver (Ag) [68], iron oxide 
(IO) and zinc oxide (ZnO) NPs as they are widely used as bactericidal agents [17,69]. These 
NPs are promising candidates, since they demonstrate greater sustainability, reduced 
toxicity, greater stability and selectivity compared to organic NPs [70,71]. Their low 
toxicity against human cells [72,73], low cost [74], inhibition effect against a broad range 
of bacteria and inhibition of biofilm formation [75] makes them fitting for application as 
antibacterial agents in biomedical industries [76], food additives [77], fabric [75], and 
skincare products [78]. Studies using both chemical and green synthesis of NPs have been 
included. The green synthesis is a growing domain of bio-nanotechnology due to its low 
cost and non-toxic nature [69,79,80]. 
 Inclusion criteria for the studies include English language, original studies focusing on 
the antibacterial properties of NPs, published in the last decade, and in vitro studies. 
 Exclusion criteria include reviews, case reports, studies with binary results, studies 
that demonstrated results only in figures. 
A total of 85 papers were selected and 60 articles were deemed relevant to this study. 
We concentrated on in vitro studies due to the significant benefits they offer in agreement 
with the three R’s movement (replace, reduce and refine the animal experiments), reduced 
costs and allowing direct evaluation without the influence of pharmacokinetic variables 
[81]. 
2.2. Data Extraction 
2.2.1. Input Extraction 
Each paper was reviewed with a focus on (i) the type of NPs (IONPs, AgNPs, 
ZnONPs) [2,82]; (ii) the nano-specific descriptors (core size, shape, zeta potential, surface 
area, etc.) [83]; and (iii) the study design experimental parameters (exposure conditions 
and bacteria characteristics) [84]. The above variables were acquired as input attributes 
for the prediction of the antibacterial efficiency of the investigated NPs. 
2.2.2. Outcome Extraction 
For the evaluation of the antibacterial efficacy, studies reported different assays and 
techniques. Several outcomes based on antibacterial measurements were documented, 
such as bacteria viability, zone of inhibition (ZOI), minimum inhibitory concentration 
(MIC), minimum bactericidal concentration (MBC), colony-forming unit (CFU), optical 
density (OD), and inhibition in biofilm formation. Different metrics and expressions were 
shown in output values which stressed the fact that a standardized method and reporting 
of scientific data is required. 
2.3. Data Pre-Processing 
2.3.1. Missing Values 
In the initial raw dataset (Dataset I), missing data occurred in all the extracted 
attributes. Following the selection of the outcome, we created the final dataset (Dataset 
II). Our final data had few missing values among the inputs. As regression models cannot 
perform well with null data, we deleted the rows with missing values [85]. 
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2.3.2. One Hot Encoding 
In regression models, categorical variables (nominal attributes) must be converted 
into integers (numerical dummy variables). There are several conversion methods [65]; 
we created dummy variables for each of the categorical columns and integrated the new 
columns into the main data frame. The value 0 or 1 was used to denote the absence or 
presence of the original attributes. 
2.3.3. Normalization 
Data normalization was conducted on the numeric inputs to enhance model 
performance. Normalization is achieved by different techniques such as Z-score, min-
max, mean and median absolute deviation scaling [86]. Normalization was done by 
applying a z-score that standardizes a feature to have zero mean unit variance [87]. 
 ′ ,   = ( ( ,  ) −   )/   (1) 
where x represents the features in the dataset, μ the mean and σ the standard deviation of 
the i, n features. 
2.3.4. Data Split 
For a supervised computational algorithm to predict outputs of an unknown target 
function, a training set is provided initially. We randomly split the data into two sets, one 
to train the model (training set) containing 70% of the dataset and the rest ones (30%) for 
testing the performance (test set) [88]. 
2.4. Regression Models 
The regression technique constructs a model with the ability to predict new numeric 
values from the input variables. Regression modeling is the task of approximating a 
mapping function from inputs to a continuous output [89,90]. The ML algorithm maps 
functions from NP’s p-chem properties and experimental conditions to the inhibition of 
bacteria and enables the prediction of the antibacterial capacity of NPs. We used several 
supervised regression algorithms as potential candidates for developing our model to 
explore which model can provide the most accurate prediction. The Least Absolute 
Shrinkage and Selection Operator (LASSO) Regression, Ridge Regression (RR), Elastic Net 
Regression (ENR), Random Forest (RF) and Support Vector Machine (SVM) are examined 
in this study. Models were built in Python version 3.7.6, Scikit-learn version 0.24.1. 
LASSO regression is a popular variable selection and shrinkage estimation method 
[91] which finds the variables and corresponding regression coefficients that lead to a 
model with higher accuracy. This is accomplished by imposing a restriction on model 
parameters, which then ‘shrinks’ the regression coefficients close to zero. Variables with 
a regression coefficient of zero after shrinkage are excluded from the model [92]. 
RR is a simple approach [93] that addresses the collinearity challenge arising in 
multiple linear regression [94–96]. When the covariates are super-collinear, two or 
multiple covariates are strongly related. When there is multicollinearity, least squares 
estimates are unbiased and their differences are larger, so they may be far from the real 
value. By adding a scale of bias to the estimates, RR decreases the standard errors. The RR 
model gives different importance weights to the features but does not drop unimportant 
features in comparison with LASSO [97]. 
ENR applies the penalties from both the LASSO and RR methods to regularize 
regression models [98]. ENR often outperforms LASSO, which is particularly useful when 
the number of predictors is much bigger than the number of observations [98]. This 
method aims to improve predictions by performing variable selection by forcing the 
coefficients of “non-significant” variables towards zero (shrinkage) [92]. 
RF comprises various decision trees that are trained independently on a random 
subset of data. RF can work with thousands of variables without deletion or reduction in 
accuracy, while preventing overfitting [99,100]. As a classifier, RF performs an implicit 
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feature selection, using a small subset of “strong variables” for the classification, which is 
the reason for its superior performance on high dimensional data [101]. 
SVM learns by assigning labels to objects and is widely used in biological fields. It is 
used for both classification and regression challenges [102,103]. In SVM, each data item is 
plot as a point in an n-dimensional space with the value of each feature related to the value 
of a specific coordinate. It performs classification by finding the hyper-plane that 
differentiates the two classes. 
2.5. Model Validation 
The primary objective of ML is to generate an effective computational model with a 
high predictive capacity. Cross-validation is used to guarantee a stable assessment of the 
model performance and to avoid overfitting [104,105]. In cross-validation, the model is 
trained using parts of the training set by leaving one subset for later testing. 
To produce an optimal model, a balance to avoid both underfitting and overfitting 
by adjusting hyperparameters is critical. In LASSO, RIDGE, and EN models, several 
statistical techniques were used to evaluate the model (data not shown) by using different 
sets of alpha values. To tune LASSO, RR and ENR models, we performed a “grid search” 
approach. The approach reduces the model’s complexity by keeping the most important 
features. The higher the alpha value, the more the regularization parameter influences the 
final model, hence decreasing the error due to variance (overfit). Alpha in regression 
models takes various values, however, when α = 0, the model gets same coefficients as in 
simple linear regression (no regularization). 
The models were evaluated by mean absolute error (MAE), mean square error (MSE), 
root mean square error (RMSE) and Coefficient of Determination or R-squared (R2). 
MAE is a popular metric, calculated as follows: 





where yi is the i’th expected value in the dataset,   
^ is the i’th predicted value. 
MSE is a standard and common error metric for regression model problems. The MSE 
is analyzed as the mean or average of the squared differences between predicted and 
expected target values in a dataset. It can be calculated by 






where yi is the i’th expected value in the dataset and   
^ is the i’th predicted value. 
The RMSE of expected and predicted values can be calculated through the √MSE. 
Although a good RMSE value is relative to a dataset, the smaller the value, the better the 
predictive model. 
R2 is a statistical measure of fit that suggests how much variation of the output is 
supported by the inputs. R2 explains to what degree the variance of one variable describes 
the variance of the second variable. For instance, if R2 is 0.70, then approximately 70 
percent of the observed variation can be explained by the model’s inputs, and the greater 
the R2 value, the better is the model. 
2.6. Important Attribute Analysis 
Attribute importance is a supervised event that distinguishes and ranks the attributes 
that are most important in predicting the outcome in a relative manner [106]. Attribute 
importance was derived through random forest optimization (built-in function). The 
analysis is based on the Gini importance, an all-nodes accumulating quantity that 
indicates how often a particular attribute was selected for a split, and how large its overall 
discriminative effect was in the regression [100]. Information values range from 0 to 1, 
with 1 representing maximum information gain. 




3.1. Data Pre-Processing 
The primary dataset comprised 1176 rows and 18 columns (11 inputs, 7 outputs) 
extracted from 60 studies investigating the antibacterial properties of the NPs. 
Input selection and transformation: The input data consisted of specific surface area 
(m2/g), hydrodynamic size (nm), zeta potential (measured in water and medium) (mV), 
core size (nm), exposure dose (μg/mL), and duration (h) reported in numeric values. 
Variables with nominal values included shape, type of NPs, coating, bacterium and 
aggregation as summarized in Table 1. As can be seen from Figure 2 (left), specific surface 
area, hydrodynamic size and zeta potential had approximately more than 90% missing 
values and were therefore excluded. The aggregation potential had 39% missing data and 
therefore was discharged. The different types of NPs, coating, duration, and bacteria had 
no missing values. The dose, shape, and core size had 17.3%, 13.5%, and 9.6% missing 
values, respectively. 
The coating and bacteria variables were very dispersed (as illustrated in Figure 3). To 
prevent model overfitting, we transformed coating into coated and uncoated (binary 
format). The studies were conducted on several strains of bacteria for which we collected 
the class, family, and species information. To avoid overloading the model we only kept 
species as a subcategory of class and family, grasping general (Gram-positive or negative 
bacteria) and specific information. In the final dataset (Dataset II), we included shape with 
11%, dose with 9.8% and core-size with 5% missing values. The other variables had no 
missing values. 
Outcome Selection: We gathered all the evaluations used to determine the 
antibacterial efficacy of the NPs. Each of the outcomes has different unit metrics. For 
example, the bacteria viability/growth is expressed in the number of bacteria cells and cell 
viability is reported as a percentage of live bacteria. ZOI is given in mm, representing the 
diameter of the area of media where bacteria are unable to grow [107]. MIC is extracted in 
μg/mL as the minimum concentration of NPs that inhibit the growth of bacterium [107]. 
MBC is expressed in μg/mL as the lowest concentration of antibacterial agent required to 
kill a bacterium [108]. OD measurements represent growth analysis by measuring the 
optical density at different settings of 580, 600 and 572 nm. The biofilm formation is 
reported in a percentage and change in biofilm growth is reported in colony-formed unit 
(CFU) [109]. 
Due to the high occurrence of missing data and diversity in the outcomes (as shown 
in Figure 2), we chose the outcome with the least missing value, the inhibition zone 
measurement (ZOI) in mm, with 60% missing values. Hence, the rest of the outcomes were 
dismissed in Dataset II. ZOI testing, also known as the disk diffusion method (DDM), is a 
fast and inexpensive assay compared to the other laboratory tests [110,111]. The diameter 
of the ZOI illustrates the antimicrobial activity present in the sample or product—a larger 
zone of inhibition means that the antimicrobial is more potent. In summary, the final 
dataset of 436 rows consists of seven inputs (shape, dose, size, coating, type of NPs, 
bacteria species, and duration as inputs) and one output (ZOI) derived from 60 studies. 
Table 1. The primary and final Input variables in Dataset I and Dataset II. 


















1.2–96 (m2/g), NA 
Eliminated due to 
high NA 
− 
Hydro_size 11.5–993 nm, NA − 
Zeta_Medium −40–90 (mV), NA − 
Zeta_Water −40–80 (mV), NA − 
Core_size 2–1000 (nm), NA Selected 4–546 (nm), NA 





Yes, None, NA 




Spherical, Hexagonal, Rod, Spindle, Disc, 
Cubic, NA Selected 
Spherical, Hexagonal, 
Rod, Cubic, NA 
NPs type AgNPs, Fe3O4, ZnO AgNPs, Fe3O4, ZnO 
Coating 
Iron Oxide, dextran, pullulan, Taraxacum 
officinale, Aspergillus, Emericella nidulans, 
Tannic acid, quercetin, TXT_100, SDBD, SDS, 
Tween 81, PEG, PVP, Crataeva nurvala, 
PMC, PG, Moringa oleifere, Oleic acid, Zinc 
oxide, Gold, Chitosan, APTES, Flaxseed oil, 
silver, CES, alginate, PVA, Carbon, Alow 














0.01–10.000 (μg/mL), NA 
Selected 
0.01–10.000 (μg/mL), Na 










Acetomicrobium faecale, Acidaminococcus 
fermentans, Actinomyces denticolens, Aspergilus 
(niger, terreus strain), Bacillus brevis, Bacillus 
cereus, Bacillus subtilis, Bacteroides (eggerthii, 
stercoris, thetaiotaomicron, uniformis, vulgatus, 
xylanolyticus), Bifidobacterium (adolescentis, 
bifidum, longum, suis, thermophilum), 
Campylobacter jejuni, Candida (albicans, 
parapsilosis, tropicalis), Citrobacter freundii, 
Clostridium (butyicum, cellulovorans, coccoides, 
histolyticum, leptum, perfringens, 
thermocellum), Corynebacterium glutamicum, 
Enterobacter (aerogenes, cloacae), Enterococcus 
(cecorum, durans, faecalis, faecium, hirae), 
Escherichia coli, Eubacterium eligens, Fusarium 
solani, Ganoderma, Klebsiella (aerogenes, 
oxytoca, pneumoniae), Lactobacillus 
(acidophilus, amylovorus, casei, fermentum, 
johnsonii, plantarum, reuteri, salivarius), 
Leuconostoc (citreum, fallax, lactis, 
mesenteroides), Listeria monocytogenes, 
Microbacterium hominis, Neisseria canis, 
Olsenella (profusa, uli), Proteus (mirabilis, 
vulgaris), Pseudomonas aeruginosa, Putida 
vulgaris, Ralstonia solanacearum, Salmonella 
(Enteritidis, paratyphi, typhi,typhimurium), 
Serratia marcescens, Shigella (dysenteriae, 
sonnei), Staphylococcus (aureus, epidermidis), 
Streptococcus (aureus, epidermidis, bovis, 
gallolyticus, hyointestinalis, porcinus, 
pyogenes,salivarius), Veillonella ratti, Vibrio 






A. niger, A. terreus, 
Aspergillus, B. brevis, B. 
cereus, B. licheniformis, B. 
subtilis, C. albicans, C. 
tropicalis, E. aerogenes, E. 
coli, E. faecalis, 
Enterococcus, F. solani, 
Fusarium, Ganoderma, K. 
pneumoniae, L. 
monocytogenes, P. 
aeruginosa, P. mirabilis,P. 
multocida, P. putida, P. 
vulgaris, Penicillium, S. 
aureus, S. dysenteriae, S. 
epidermidis, S. marcescens, 
S. paratyphi, S. typhi, 
Salmonella, Scedosporium, 
Shigella, V. cholerae, X. 
oryzae, Xanthomonas 




Figure 2. Dataset I. Missing values (percentages) of input and output parameters (left). Dataset II 
missing values of inputs and one outcome, ZOI (right). 
 
Figure 3. Coating information of NP, the coating variables are all 57% and the un-coated is 43% (a). Species of several 
investigated foodborne and environmental bacterium (b). 
3.2. Validation of Models and Attribute Analysis 
Following data homogenization and pre-processing, we trained various regression 
models. Model performance results are presented in Figure 4a. The results suggest that 
the RF model exhibits the lowest error and the highest R2 score compared to the other 
algorithms employed (LASSO, RR, ENR, SVM), with R2, RMSE, MAE and MSE of 0.78, 
4.30, 2.78 and 18.56 values, respectively. The outcome of attribute importance analysis is 
shown in Figure 4b. Core-size is the most important attribute that determines the efficacy 
of the antibacterial effect of NPs. The dose, species, and type of NPs are identified as 
comparatively important, followed by coating, shape, and duration. Further data analysis 
such as correlation and batch effects are presented in Supplementary Materials (S2). 




Figure 4. Performance metrics (a) and Random Forest Attribute Importance analysis results (b). 
4. Discussion 
In the present study, we implemented an ML tool from data collection to model 
validation, to predict the bactericidal effects induced by NPs in in-vitro systems. The 
model is consistent with the OECD principles [112] addressing the selection of (i) a defined 
endpoint (zone of inhibition as a metric to evaluate the susceptibility of the bacteria to 
NPs); (ii) an explicit algorithm (RF, https://github.com/mahsa-mirzaei/RFR_ABA.git, 
accessed on 6 July 2021); (iii) a well-defined domain of applicability (data ranges and 
nominal categories are provided, Table 1); and (iv) appropriate measures of goodness-of-
fit; robustness and predictability. 
Recent studies have demonstrated that p-chem properties such as core-size [113], 
shape [114], surface area [115], zeta potential [116], aggregation [117], and hydrodynamic 
size [115] play an important role in determining the antibacterial activity of NPs [116,118]. 
Exposure conditions such as dose play an important role as well [119]. For the above 
reasons, we gathered information regarding the p-chem properties of NPs and exposure 
conditions. However, the appearance of missing data among our input was significant. 
For instance, specific surface area, hydrodynamic size, and zeta potential were absent in 
more than 90% of our data, aggregation information was 39% missing. Although this is 
essential information, regression tools do not perform well with missing data. P-chem 
properties are important factors and should be mentioned in future studies. Another point 
is the appearance of multiple diverse coatings found in the literature. In our dataset we 
found thirty-seven coatings (less than 4% each and 43% uncoated). For the moment, the 
dataset is not sufficiently large to distinguish the influence and variance of each coating 
to the antibacterial capacity since the models overfit (reduction in predictive power). 
In the studies reviewed, different methods to determine the NP size and morphology, 
such as Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM), 
Differential Mobility Analyzer (DMA), Dynamic Light Scattering (DLS), X-ray scattering, 
and UV–vis absorption spectrum, were reported. The presence of coating was assessed 
using electron microscopy combined with X-ray (energy-dispersive X-ray spectroscopy, 
EDX) or X-ray fluorescence spectroscopy (XRF) measurements. The specific surface area 
was measured by N2-BET, Ultra X-ray photoelectron spectroscopy technique, and NMR. 
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The zeta potential was measured in different media (water and culture media) by 
electrophoretic mobility using Henry’s Equation and the Schmolukowski approximation. 
The above summary signifies the need for a standardized characterization workflow to 
obtain homogenized data across different studies. 
The reviewed studies captured the antibacterial effects of NPs by using different 
protocols. To create a consistent dataset, the experimental data should be generated by a 
single protocol, but this is impractical. For the outcome we focused on one antibacterial 
evaluation method to obtain uniform data, which represented only 40% of the gathered 
data. Subsequently, it demonstrates the need for harmonized and rigorous methods used 
to evaluate the antibacterial activity of NPs to accomplish reproducibility as well as 
reliability. 
RF has been effectively utilized in various domains, e.g., in microbiology and 
genetics, and has become a major data analysis tool due to its superior performance on 
high dimensional data [101,120,121]. Our results show that RF predicts the antibacterial 
effect more acutely compared to other models due to the determination of the non-linear 
relationship between input and output variables. The second-best model was LASSO. The 
key challenge with LASSO is correlated variables, in that it retains one variable and sets 
the other to zero. This will lead to some loss of information resulting in lower accuracy. 
In order to evaluate the reliability and performance of the resulting models, we assessed 
the goodness-of-fit, robustness and predictivity by MSE, MAE, RMSE, and R2 statical 
methods. The closer the value of R2 (measures of goodness-of-fit) to 1, the better the model 
is fitted [122]; smaller values of MSE, RMSE, and MAE verified model performance 
[123,124]. 
Several techniques exist for pre-processing data to make them suitable for use in 
computational tools, such as normalization, one hot encoding, and feature selection 
handling of missing values. One technique worth noting is the description of molecular 
structures [125]. The most common methods to codify structures are (i) the chemical 
graph; (ii) the notations as Simplified Molecular Input-Line Entry System (SMILES); and 
iii) the de-facto standard chemical formats. Experimental and exposure conditions are 
vital variables in the representation of antibacterial capacity since the same type of NPs 
may exhibit diverse effects in different experimental conditions. This makes the 
development of classic QSAR difficult [126]. Toropova et al. [127] suggested a quasi-
SMILES approach to represent molecular structures, p-chem properties, and experimental 
conditions (eclectic data) with NPs [126,128]. 
There was no ML study to compare with as to which parameters are the most 
important to predict the antibacterial activity of NPs on the model performance. We based 
our evaluation on the attributes that are investigated by researchers in the lab [129]. For 
example, according to the literature, various parameters such as core size, dose, shape, 
and special surface area of the NPs affect the antibacterial activity of NPs [118,130]. 
 Size: The smaller the particle size, the higher the antibacterial activity [118]. This can 
be explained by the fact that NPs can easily cross the bacteria membrane and reach 
the nuclear; secondly, because of a larger surface/volume ratio [131–134]. 
 Species: Type of bacteria is important in determining the antibacterial activity of the 
NPs [135–137]. Depending on their cell wall composition, bacteria are divided into 
two groups: Gram-negative and Gram-positive [138]. Various NPs with different 
surface charges can act distinctly depending on what the differentiation is in the 
bacteria cell wall composition [132,135]. 
 Dose: A dose-dependent reduction of bacterial growth and biofilm biomass is 
observed following exposure to metal and metal oxide NPs [139,140]. Remarkably, 
our findings, according to the attribute important analysis, confirm that the core size, 
dose, and bacteria species are the most important attributes affecting the prediction 
of the antibacterial activity of NPs. 
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More systematic data are needed to enable building models accounting accurately 
for the all the possible in vitro determinant combinations. Without agreement on standard 
characterization workflow of NPs or defined key properties that define their efficacy and 
a lack of reference bacteria and defined assays, there is still a long way to go to unravel 
systematically the antibacterial properties of NPs. In addition to precise protocols and 
standardization of methods, there should be further harmonized outlines in how to report 
p-chem properties of NPs or experimental conditions and to make those measurements 
more comparable to improve the reporting data. The absence of comprehensive metadata 
description for related bioassays may have an impact on the clarity and comprehension 
and therefore the quality of the results [141]. Several different initiatives are currently 
working on defining frameworks, methods, and criteria for evaluating the quality of the 
reported data based on the FAIR (Findable, Accessible, Interoperable, Reusable) data 
principles [142]. 
5. Conclusions 
Antibiotic resistance of bacteria has become one of the major concerns in human 
healthcare. NPs represent a valuable and innovative technology to build alternatives to 
antibiotics. In this study, we investigate the performance of various ML tools to predict 
the effects of NPs as an antibacterial agent on vast groups of Gram-positive and Gram-
negative bacteria, with RF being the best model. This study is a first step and the first tool 
to assist researchers towards screening NPs with potentially high antibacterial effects and 
could help fine-tune their properties. With this interdisciplinary approach we combine 
knowledge of the underlying science with computer science tools. This is a valuable 
activity as it allows those working in the laboratories to leverage development in the AI 
space and thus improve timeliness, reducing the number of experiments performed and 
the costs involved. Due to the inconsistency of reporting NP p-chem properties in 
antibacterial studies, the resulting dataset has large data gaps. We highlight the need for 
standardized measurements to evaluate the properties of NPs, allowing more consistent 
metadata. The majority of data in the literature revolves around the toxicity of NPs. This 
paper stresses the need for more data, raising awareness to the scientific community of 
the lack of comprehensive datasets regarding the antimicrobial capacity of NPs. 
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Fe2O3 NPs Iron Oxide nanoparticles 
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